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Abstract. Mechanical strength Of the red cell mem- 
brane is dependent on ternary interactions among the 
skeletal proteins, spectrin, actin, and protein 4.1. Pro- 
tein 4.1's spectrin-actin-binding (SAB) domain is speci- 
fied by an alternatively spliced exon encoding 21 amino 
acid (aa) and a constitutive exon encoding 59 aa. A se- 
ries of truncated SAB peptides were engineered to de- 
fine the sequences involved in spectrin-actin interac- 
tions, and also membrane strength. Analysis of in vitro 
supramolecular assemblies showed that gelation activ- 
ity of SAB peptides correlates with their ability to re- 
cruit a critical amount of spectrin into the complex to 
cross-link actin filaments. Also, several SAB peptides 
appeared to exhibit a weak, cooperative actin-binding 
activity which mapped to the first 26 residues of the 
constitutive 59 aa. Fluorescence-imaged microdeforma- 
tion was used to show SAB peptide integration into the 
elastic skeletal network of spectrin, actin, and protein 
4.1. In situ membrane-binding and membrane-strength- 
ening abilities of the SAB peptides correlated with 
their in vitro gelation activity. The findings imply that 
sites for strong spectrin binding include both the alter- 
native 21-aa cassette and a conserved region near the 
middle of the 59 aa. However, it is shown that only 
weak SAB affinity is necessary for physiologically  rele- 
vant action. Alternatively spliced exons can thus trans- 
late into strong modulation of specific protein interac- 
tions, economizing protein function in the cell without, 
in and of themselves, imparting unique function. 
T 
HE erythrocyte is among the simplest and best char- 
acterized of cellular systems within which the chem- 
istry of composition can be  intricately related to 
structural function. Indeed, most of the red cell's mechani- 
cal behavior, except for limited aspects  of cell shape, ap- 
pears to depend little on the complexities  of intracellular 
metabolism  (14). However,  to  withstand  the  forces  of 
blood  flow over  a  several-month lifespan,  the  erythro- 
cyte's membrane components must assemble into a highly 
durable structure. Physical limits to this durability are set 
by the system's mechanochemistry, which is defined here 
as those molecular interactions that permit a pliable,  yet 
resilient structure. 
Spectrin,  actin,  and protein 4.1 are the principal struc- 
tural proteins of the thin, cohesive  skeletal network that 
underlies the red cell's lipid bilayer (3, 5, 19). The network 
formed by these highly conserved and pervasive  proteins 
confers resilience and durability to the red cell's composite 
membrane (14, 16, 36, 44, 46). Mixtures of these network 
proteins also  show that they can form very stable  com- 
plexes  in vitro (37) which at approximately micromolar 
protein concentrations can undergo a phase transition to a 
three-dimensional gel (7, 15, 49). In the formation of the 
basic ternary complex, protein 4.1 appears to play a crucial 
role in stabilizing  spectrin cross-links between actin fila- 
ments. Consistent with cross-link reinforcement, red cells 
deficient in protein 4.1 possess membranes that fragment 
more  readily than normal when exposed  to  high  fluid 
shear (46, 51). 
The crucial stabilizing function of protein 4.1 (~80 kD) 
localizes  to  a  relatively small  (~10-kD)  spectrin-actin- 
binding domain (SAB)  1 (10) whose function recently has 
been shown to be strongly modulated at the genetic level 
by alternative splicing. The SAB isoform expressed in the 
erythrocyte is encoded by two exons that translate to an 
alternative NH2-terminal  21-amino  acid  (aa)  "cassette" 
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combinant isoform constructs of the SAB (11, 24) demon- 
strated  that  inclusion  of the  21-aa cassette is  critical for 
spectrin binding and also for efficient, 4.l-like activity in 
both ternary complex formation and membrane strength- 
ening.  Whether  the  21-aa  peptide,  by itself,  completely 
specifies these biochemical and biophysical properties was 
not  addressed.  Neither was it  determined  whether  SAB 
isoforms lacking the 21aa are completely inactive, or sim- 
ply much less efficient in some functions. 
To dissect methodically such issues of protein function- 
ality,  COOH-terminal  deletants  of  the  SAB  were  con- 
structed (see Fig. 1) and their functions characterized. We 
found  that  the  21  aa  cassette plus  43  residues  from the 
downstream sequence (peptide designation 21.43)  are re- 
quired  for strong, 4.l-like  interactions  with  spectrin  and 
actin. Ternary complex formation in vitro, however, does 
not strictly require  the  21  aa, but  does need  at least the 
first 26  residues  of the  downstream sequence  in  tandem 
with  either  the  NH2-terminal  21-aa  cassette  (to  give  a 
functional 21.26 peptide) or additional residues from the 
59-aa domain (yielding a functional 0.59 peptide). 
The physiological relevance of these in vitro results to 
both binding and mechanically strengthening intact mem- 
branes was also addressed. SAB peptide binding to normal 
membranes shows a highly specific, spectrin-dependent in- 
teraction.  Integration of SAB peptide into a  solidlike cy- 
toskeletal network beneath the red cell bilayer is visually 
demonstrated  by fluorescence  imaged microdeformation 
(FIMD) (12). The strengthening effect of each SAB pep- 
tide on 4.1-deficient membranes is assessed in parallel with 
membrane binding; as found in vitro, the 21.43  is the most 
potent and effective at micromolar concentrations, while 
both the 21.26 and 0.59 are capable of strengthening mem- 
branes,  but  only at much higher peptide concentrations. 
The 21.20 is completely nonfunctional, even up to concen- 
trations  of N250  ~M.  Since both the 21.26  and  the  0.59, 
but not the 21.20  are functional, the first 26 residues ap- 
pear  to  constitute  an  actin-binding  site,  and  sequences 
flanking either side of this site seem essential for spectrin 
interactions.  It  therefore  appears  that  actin  binding  in 
combination with even weak spectrin binding is sufficient, 
if not materially efficient, for network integration, stabili- 
zation, and structural strengthening. 
Materials and Methods 
Construction  and Expression  of SAB Peptides 
SAB domain deletion constructs (Fig. 1) were generated from a minigene 
encoding slightly more  than the SAB  domain of erythroid protein 4.1 
(Glu'~°°--~Gly  487) previously denoted 10k  21 (11). Escherichia coli-expressed 
peptides were either affinity purified as glutathione-S-transferase (GST) 
fusion peptides or cleaved off the GST moiety by digestion with thrombin 
(20).  Additional constructs to those in Fig. 1 included a 21.41,  a 21.36, and 
a 21.31.  A  fusion peptide with the Xenopus  laevis SAB (Mays, K. T., R. 
Winardi, L. Zon, N. Mohandas, and J. G. Conboy. 1992. Blood. 80:273a.) 
was designated GST-XEN. Peptides were metabolically labeled by induc- 
ing the culture in a  methionine-free minimal essential medium supple- 
mented  with  [3SS]methionine and  Luria  broth  (15%  vol/vol).  Primary 
structures were partially confirmed by immunoblotting (11). NH2-termi- 
nal sequencing and mass spectrometry (Schischmanoff,  P. O., unpublished 
data) further confirmed expression of the constructed sequences to within 
~2 D. Peptide absorption spectra displayed the shapes expected (6) from 
Figure 1.  Deletion and isoform constructs  of protein 4.1's SAB 
domain.  The  two  gray regions  show  complete identity  in  se- 
quence with the X. laevis SAB (Mays, K. T., R. Winardi, L. Zon, 
N. Mohandas,  and J. G. Conboy.  1992. Blood. 80:273a). Within 
each of these two regions, at Tyr  418 (45) and Set  467 (23), are sites 
for phosophorylation.  Overall identity with X. laevis SAB is 75% 
with conservative amino acid substitutions  accounting for the dif- 
ferences. 
the relative Tyr and Trp composition; spectrophotometry was therefore 
used to quantify protein concentration (31). 
Falling Ball Viscometry and Spectrin  Composition 
of Networks 
The ability of recombinant peptides to form a  supramolecular complex 
with spectrin and actin was assayed by falling ball viscometry (9). Purified 
spectrin tetramer (40, 50) and rabbit muscle F-actin (38) were mixed (at 
1.8  and  14  ~M, respectively) and the recombinant peptide  was subse- 
quently added (up to ~250 I~M). The solution was drawn quickly into a 
50-100-1~1 microcapillary and  assayed by falling ball  viscometry as  de- 
scribed elsewhere  (11).  For  composition of spectrin-actin peptide  net- 
works, protein mixtures were either prepared directly in ultramicrofuge 
tubes or  transferred  from  a  microcapillary.  Centrifugation,  sometimes 
through a sucrose cushion, at 80 krpm, 22°C, for 7 min in a rotor (TLA- 
100; Beckman Instruments, Inc., Fullerton, CA) was followed by electro- 
phoresis and densitometry (IS-1000; Alpha Innotech Corp., San Leandro, 
CA). Nearly all of the actin appeared in the pellets. 
Actin Filaments Cosedimentation  Assay 
Fusion or thrombin-cleaved, asS-labeled proteins were incubated in thick- 
walled, ultramicrofuge tubes with a mixture of spectrin (2 I~M) and actin 
(7 ixM) in parallel with a control tube having the same amount of peptide 
without spectrin-actin. The total volume was 50-100 Ixl, and included 50 
~M BSA. After i  h at 37°C, all tubes, up to 10 pairs, were centrifuged to- 
gether as above. The supernatants and pellets were counted; the amount 
of bound peptide was typically determined from the difference in peptide 
concentrations in the superuatants of the sample and control tubes. 
Membrane-binding  Meihod 
Typically, a  small volume of in vitro translated aSS-labeled  peptides was 
mixed with 400 ~l of normal membranes. The membranes were obtained 
by simple hypotonic lysis (10 mM sodium phosphate, 4°C). The mixture of 
membranes plus peptides was incubated on ice for 20 min (47). To obtain 
resealed "ghosts" (cells with much reduced hemoglobin), salt was added 
(100 mM KC1, 1 mM MgC12), and the membranes were incubated at 37°C 
for 30~50 rain. After resealing, unbound peptide was washed away with 
isotonic PBS. The washed ghosts were then lysed a second time and rap- 
idly washed in 10 vol of lysis buffer to extract internally free peptide. The 
pelleted membranes and aliquots from each wash were counted. All cen- 
trifugations were done at 15 krpm for 3 min in a 4°C rotor (SS-34; DuPont 
Instruments, Sorvall Biomedical Division, Wilmington, DE). 
FIMD 
The micropipette  aspiration  technique is based upon previous descrip- 
tions (13)  with equipment differences and an image calibration scheme 
elaborated elsewhere (12).  Details of fluorescent probes and membrane 
labeling are described elsewhere (12, 18). Labeling of skeletal F-aetin was 
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purified and labeled by previous methods with FITC (39, 48). Iodoacetim- 
ido-5-fluorescein (IAF)  was conjugated to  GST-21.43  and recombinant 
GST. Polyclonal IgGs to the ct-II(44) domain of ct-spectrin (S. Marchesi, 
Yale  University, New  Haven, CT)  were  proteolysed  to  antibody  frag- 
ments and labeled with FITC. To emulate synthetically a lipid- or glyco- 
sylphosphatidylinositol (GPI)-linked  protein  on  the  red  cell's  surface, 
Texas red-conjugated polyclonal IgGs against fluorescein were bound to 
fluorescein-phosphatidylethanolamine- (FL-PE) labeled red cells. 
Calculation  of Network Conformation 
from Density Profiles 
For an initial perspective of the analysis, deformation of a linear spring is 
characterized  by  one  stretch  ratio  that  indicates  how  the  spring  is 
stretched from an initial length L to a final length kL. For an axisymmetric 
elastic surface  deformed  to  a  second  axisymmetric surface,  the  shape 
change and all geometric quantities are fully described by two stretch ra- 
tios, hi and k2, which are continuous functions of position along orthogo- 
hal lines of curvature on the surface (14, and references therein). As an 
important application, if the surface density (mass per area) at a material 
point initially is Po, then the final density, p, at that point is determined by 
how it is stretched: p  =  po/Xlk2. A  relative density can also be defined as 
P  =  P/Po =  1/(klX2). The relative density of network components is ob- 
tained from FIMD (12) and the network stretches may be calculated by 
integration (Discher, D., unpublished calculations). 
Red Cell Membrane Fragmentation  Assays 
The strength of membranes in a shearing flow was qualitatively assessed 
in vitro  as described  elsewhere  (4,  11).  Typically, 150-250  p.1 of mem- 
branes was added to an equal volume of peptide. Normal and 4.1-deficient 
membranes incubated with lysis buffer instead of peptide served as posi- 
tive and negative controls, respectively. 
Results 
Interactions with Spectrin-Actin In Vitro Show 
Minimal Functional Peptides Are the 21.26 and 0.59 
The primary goal of this work was to elucidate the mecha- 
nism of SAB function in the red cell where the dominant 
interactions of protein 4.1's SAB occur in a  ternary com- 
plex formed with F-actin and (limiting) amounts of spec- 
trin at the membrane. The studies presented below there- 
fore focus on this three-component system. 
By analyzing the abilities of recombinant SAB peptides 
to induce gelation (Fig. 2 A) when mixed with F-actin (14 
p.M)  and  limiting  spectrin  (1.8  p~M), we  first  identified 
peptides with no activity (21.10  and 21.20),  weak activity 
(21.26 and 0.59), and strong activity (21.43 and 21.59) com- 
parable to intact 4.1 (11, 15, also Schischmanoff, P. O., un- 
published results). To characterize the mechanism of this 
gelation,  spectrin  incorporation  into  sedimentable,  su- 
pramolecular assemblies was quantitated by densitometry 
after  electrophoresis  (vertical scale, Fig.  2  A).  Peptide 
21.43 was the most potent in stabilizing spectrin-actin in- 
teractions at low concentrations; its activity was again like 
that of purified 4.1. In comparison, both the 21.26 and 0.59 
were between one and two orders of magnitude less active. 
Peptides shorter than the 21.26 had no effect on spectrin 
binding to F-actin. Despite the large differences in the ac- 
tivity of these peptides, the onset of gelation was consis- 
tently within a relatively narrow concentration range cor- 
responding to 50-65 % of spectrin recruitment into ternary 
complexes (light gray, horizontal band, Fig. 2 A). Thus, the 
mechanism of network assembly and material strengthen- 
ing in vitro appears to be based on peptide-dependent sta- 
Figure 2.  Characterizations  of spectrin-actin-SAB peptide com- 
plexes as a function of SAB peptide structure and concentration. 
(A) Viscometry and spectrin  cosedimentation assays of peptides 
mixed with set concentrations of spectrin (1.8 p,M) and actin (14 
ixM). Datapoints indicate  both the typical gelation state of the 
mixtures and the amount of spectrin cosedimenting  with F-actin. 
Data fits are calculated with the ternary complex model (see Re- 
suits) with parameters listed in Table I. The dark gray zone indi- 
cates a consistently obtained gel state for the mixtures. The light 
gray transition  zone covers the range of variation found in the ge- 
lation point among a large number of experiments.  Peptide 21.20 
did  not alter mixture viscosity at peptide concentrations  up to 
N250  p~M. The weak spectrin-actin  interaction leads  to  some 
cosedimentation of spectrin  in the absence of any peptide. Both 
GST fusion peptides and the thrombin-cleaved counterparts gave 
similar  results.  (B)  35S-peptide cosedimentation  with  purified 
spectrin (2 txM) and actin (7 IxM). Error bars indicate  the range 
in data after combining  multiple  experiments.  Data fits are de- 
scribed in the text and summarized in Table I. 
bilization  of  some  critical  number  density  of  spectrin 
cross-links between actin filaments. 
In related  experiments, cosedimentation of 35S-labeled 
SAB peptides with F-actin (7 p,M) and limiting spectrin (2 
~M) revealed a two-phase binding process (Fig. 2 B). The 
21.43  bound  readily  into  the  ternary  complex  until  the 
spectrin appeared completely complexed with peptide and 
actin  at  a  stoichiometry  of ~1:1  peptide/spectrin  (inset, 
Fig. 2 B). After this first, high affinity, spectrin-dependent 
phase, there seemed to be a weak, but cooperative, second 
phase of binding consistent with a  binary interaction be- 
tween peptide and F-actin. In support of this, the second 
phase of binding saturated at the total F-actin concentra- 
tion of 7  }xM. Decreasing the total F-actin concentration 
led to a decrease in the magnitude of saturation in this sec- 
ond phase. A  weak, and apparently cooperative, interac- 
tion between actin and native, full-length 4.1 is consistent 
with previous reports (2; 36a). 
In comparison to the 21.43,  the 21.26  and 0.59 showed 
much less of the first, strong phase of spectrin-dependent 
binding, but clearly showed a  weak, second phase of ap- 
parent  actin  binding.  The  minimal  primary sequence  in 
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first 26 residues of the constitutive 59-aa domain. These 26 
residues are thus implicated as the putative actin binding 
site in the SAB. Consistent with an important role for ac- 
tin binding in structural functions like gelation, deletion 
peptides shorter than the 21.26 did not alter spectrin-actin 
interactions.  Peptide  inhibitors  of 35S-21.43 binding  in- 
cluded both unlabeled 21.43 and the Xenopus laevis SAB, 
but  did  not  include  the  small  F-actin-binding  peptide 
rhodamine-phalloidin (data not shown). 
Ternary Complex Model Includes Cooperativity in 
Weak F-Actin Binding 
A  previous analysis of ternary complex assembly (37) in- 
cluded both a  spectrin-actin  and  a  spectrin--4.1  associa- 
tion, but did not explicitly include any type of 4.1-actin in- 
teraction.  The  experiments  presented  in  that  previous 
study showed only a single, strong phase of spectrin bind- 
ing to 10 }xM actin in the presence of ~1 IxM protein 4.1. 
This ternary interaction saturated at ~1:1 in 4.1/spectrin, 
had an apparent binary association constant of ~2  ×  10  6 
M -1, and yielded a ternary association constant K3 N1012 
M -2. While experiments did not extend beyond this first 
strong phase  of ternary complex formation, the  analysis 
assumed a very weak saturable second phase of 1:1 spec- 
trin/actin interactions with a Ksa =  5 x  103 M  -1 estimated 
from a purely linear binding curve. The ratio of/(3 to Ksa 
gave  the  thermodynamic contribution  of 4.1  to  ternary 
complex  stabilization  and  since  this  ratio  exceeded  all 
prior measures  of spectrin-4.1  association constants, the 
authors  concluded  that  additional  binding  phenomena 
may contribute to ternary complex formation. 
Based in part on this 1:1:1 stoichiometry in spectrin/ac- 
tin/4.1  associations,  our binding  isotherms  for the  SAB 
constructs (Fig. 2) also suggest an initial ternary complex 
phase that uses up the limited spectrin. Our data further 
show  a  subsequent  binary  phase  of weak,  cooperative 
binding  to F-actin.  Cooperativity via  an  actin  lattice  is 
therefore proposed  in  an  approximate  ternary complex 
model  (Fig.  3).  Linear lattice  models  involving F-actin 
have been used before, for example, in matrix-based treat- 
ments (21) of cooperativity in troponin-tropomyosin bind- 
ing to filaments (33). A comparable matrix-based analysis 
has also been performed on our data (Discher, D., unpub- 
lished calculations), but, in an effort to simplify a quantita- 
tive presentation,  a  rudimentary two-term expression is 
written below for the amount of bound (B) SAB peptide 
as a function of the amount of free (F) SAB peptide: 
B = Spo(KspF)n/[l+(KspF)  n] + {Acto 
-- 8po(gspF)n/[1W(gspF)n]}(gapF)n/[l +(gapF) n]  (1) 
The  first  term  represents  spectrin-dependent  peptide- 
actin interactions in the ternary complex: peptide and spec- 
trin are considered to interact while simultaneously bound 
to different sites on the same actin subunit. This spectrin- 
dependent component of peptide binding to F-actin is gov- 
erned by an apparent binary association constant Ksp (Fig. 
3). The Hill exponent n  represents cooperativity, in that 
whenever peptides are bound on neighboring actin subunits, 
they interact, perhaps allosterically. The second term rep- 
h 
Figure  3.  Simplified  schematic 
of protein interaction  states  in 
the spectrin-actin--SAB peptide 
ternary complex. The actin fila- 
ment is indicated by a ladderlike 
lattice of subunits that can bind 
on each actin subunit one SAB 
peptide, drawn as a black circle, 
and one spectrin dimer. Cooper- 
ativity in binding  of SAB  pep- 
tides  occurs  through  nearest 
neighbor  subunits  of an  "infi- 
nitely long" actin filament. 
resents purely peptide-actin interactions; a binary associa- 
tion constant Kap governs this binding. 
The four interaction parameters for the data fits in Fig. 2 
are tabulated in Table I. For all these fits, n =  2.25. By far 
the greatest variation among the fits of the 21.43,  21.26, 
and 0.59 appeared in the spectrin-dependent binding con- 
stant  Ksp. For  the  21.43,  Ksp  was  on  average  ~20-fold 
greater than that for the 21.26,  and more than ~50-fold 
greater than that for the 0.59.  These large differences in 
spectrin-dependent  associations  offer some  explanation 
for the lack of detectable binary interactions in solution 
between  spectrin  and  either  the  0.59  (11)  or  the  21.26 
(Schischmanoff, P. O., unpublished results). Finally, for an 
approximate ternary association constant K3 (M -E)  ~  (2/ 
Spo)*Ksa, the fits listed in Table I  for the 21.43 give K3 
"-~1012  M  -2 which is in good agreement with previous de- 
terminations (38). 
SAB Peptide Binding to Normal Membranes Is 
Spectrin Dependent 
Various assays of our SAB peptides' functions inside cells 
made use of a reversible, lytic incorporation technique. To 
first elucidate the process of incorporating into a near-nor- 
mal system, low concentrations (less than or equal to na- 
nomolar) of in vitro translated SAB peptides were loaded 
into normal cell ghosts during hypotonic lysis.  The stan- 
dard incorporation process (see Materials and Methods) 
involved a 20-min lysed state on ice during which hemo- 
globin can leave the cell and peptide can diffuse into the 
cell through  a  lytic pore(s)  in  the  membrane  (27).  Re- 
sealed  but  fairly red  ghosts  were  subsequently  washed 
with PBS to remove radioactive peptide not trapped inside 
the ghosts (Fig. 4 A); the membrane-binding ability of this 
unincorporated peptide was confirmed in subsequent as- 
Table L Protein 4.1 Peptides in Ternary Complex Formation 
21.43  21.26  0.59 
*Ksp  -l ~  0.75, 0.25  14, 4  26 
Kap  -l p34  12  22  26 
n  2.25  2.25  2.25 
*Spo/.ul,/  2.0  2.0  2.0 
*Acto/zM  14, 7.25  14, 7.25  14, 7.25 
Model fit parameters for ternary complex sedimentation experiments in Fig. 2, A and 
B. Association constants are tabulated as their inverse, i.e., dissociation constant. 
*Refers to binding of peptide in ternary complex with spectrin-actin. 
:Within  10% of measured concentrations. 
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membranes. (A) Analysis  of radioactive peptide distribution  af- 
ter incorporation by hypotonic lysis of normal cells and resealing 
of the ghost membranes (see Materials and Methods). These in- 
corporations were done with 8 Ixl of each in vitro translated pep- 
tide (12-18  nM initial)  and 400 ~1 of membranes. The in vitro 
synthesis of SAB peptides provided an alternative to bacterial ex- 
pression and allowed dilute, minimally perturbing tracer studies 
to be readily performed at the same small scale used in the rest of 
the work. Resealed ghosts were washed in 10 vol of PBS three 
times (P1 to P3). The membranes were then relysed in 10 vol 
(L1), centrifuged  within 4 min, and washed twice more with lysis 
buffer (L2, L3). 35S-peptide content of all the washes  and the 
membrane pellets (M) was measured and normalized by the total 
amount of 35S-peptide added. (B) Membrane-bound peptide, as a 
homogeneous concentration, versus  the sum of remaining pep- 
tide.  The experiments as in A  were repeated at various initial 
concentrations of peptide. The inset indicates  the slope of the 
[35S]21.43 binding curves in the presence of various inhibitors:  (i) 
GST-21.59 at ~25 p.M, (ii) GST-XEN at ~25 p~M, (iii) preincuba- 
tion with  anti-21  aa IgG at ~1  ~M,  and (iv) with  no inhibitor 
present, the average slope -SD. (C) Dependence of 21.59 bound 
over free on the ghost concentration.  Pelleted ghosts were diluted 
in lysis buffer and treated as in A. Model fit of data is described in 
text. (D) Kinetics of 21.59 binding to normal membranes; experi- 
ment  and  model  calculation.  Experimental  determination  of 
binding kinetics followed A until 2, 6, or 10 min after the incuba- 
tion on ice. At each time point, the membranes were diluted  10- 
fold with lysis buffer, centrifuged  for 3 min, and the pellets and 
supernatants counted. For modeling the incorporation kinetics, it 
was assumed (19) that 2 x  105 molecules  of endogenous 4.1 per 
cell (2 ixM mean intracellular  concentration) were in competition 
with the recombinant 21.59 (at <1 nM) for 2 × 105 skeletal bind- 
ing sites (2 ~M). 
say, i.e., the free peptide is not inactive peptide. Parallel 
studies using fluorescent dextrans  (10 kD)  and quantita- 
tive fluorescence microscopy demonstrated that entrapped 
concentrations varied by <20%  among all cells in a lysed 
sample. Unbound peptide trapped inside the ghosts by re- 
sealing was released by a second lysis with washing before 
counting the membrane-bound peptide (Fig. 4 A). 
Recombinant peptides 21.59  and 21.43  bound  strongly 
to red cell membranes with a  normal content of endoge- 
nous protein 4.1 (Fig. 4, A  and B). The peptide 21.26, func- 
tional in ternary complex assays, failed to show significant 
binding to these  membranes even though the 21.26  con- 
tains  the  putative actin-binding site.  Consistent  with the 
revelation of a  strong spectrin-dependent binding ability, 
previous results showed that peptides lacking the 21 aa, in- 
cluding the 0.59,  could not bind either spectrin in vitro, or 
normal membranes in situ (11). Peptides 21.36 and 21.31 
were found to bind normal membranes only slightly better 
than the 21.26 (data not shown), suggesting that these in- 
termediate peptides also interact with spectfin only weakly. 
As a further demonstration of membrane-binding speci- 
ficity, potent inhibitors of the 35S-21.43 were shown to in- 
clude unlabeled GST-21.59, GST-XEN, an IgG against the 
21-aa cassette (inset, Fig. 4  B),  and fluorescently labeled 
GST-21.43. GST protein alone did not inhibit membrane 
binding  (data  not  shown).  In  accordance  with  the  pro- 
posed spectrin dependence, as more spectrin was added in 
the form of ghost membranes (ghost volume fraction ~b), 
membrane binding of the 35S-21.59 also increased (Fig. 4 C). 
To characterize membrane binding  kinetics and verify 
that an equilibrium could be reached within the 20 min on 
ice,  the  time-course  for  incorporation  of the  21.59  was 
studied systematically. Ghosts lysed for 10 min before the 
addition  of peptide  showed  the  same  amount  of mem- 
brane  binding  as  the  typical 20-min  reaction  on ice.  By 
then adding the 21.59 for preset intervals <10 min and not 
resealing at all, it was then found that 10 min was neces- 
sary to reach equilibrium (Fig. 4 D). Since similar binding 
was obtained in the absence of resealing, the typical 37°C 
resealing step does not appear to dramatically perturb the 
0°C equilibrium. Resealing was highly effective, however, 
since preincubating ghosts at 37°C for 10 or 30 min before 
the  addition  of peptide,  reduced  membrane  binding  by 
>90%. 
Spectrin-dependent  Competition with Endogenous 
Protein 4.1 
Binding specificity and the correlations with a strong spec- 
trin-dependent  association, particularly the lack of mem- 
brane interactions of the 21.26,  along with the use of com- 
positionally complex normal membranes (wherein [4.1]tot 
[Sp]tot)  all suggest that membrane binding is a process 
involving a  competition between the endogenous protein 
4.1  and the exogenous SAB for spectrin-dependent bind- 
ing. Hence, the equilibrium and kinetics of binding (Fig. 4) 
are analyzed as peptide, P, competing with endogenous 4.1 
for binding to skeleton, Sk: 
P  +  Sk~-->P*Sk  K  =  kf/kr  (2a) 
4.1  +  Sk~->4.1*Sk  K¢ =  ot K  (2b) 
The association constants K  and K¢ are allowed to differ 
by an accelerating factor or. We expect the skeletal sites to 
be  spectrin-dependent  binding  sites.  Also,  because  the 
spectrin-actin-binding  activities of the  21.43  and  4.1  ap- 
peared  equivalent  in  vitro,  the  factor ot is  intended  pri- 
marily to capture the effect of protein 4.1's additional in- 
teractions with the  cytoplasmic domains  of both band  3 
and the glycophorins (29,  17).  These interactions tend to 
concentrate the endogenous 4.1 to the red cell's periphery 
in the region of the skeleton, accelerating protein 4.1's in- 
teractions with skeletal components. 
The  fractional  saturation  of  the  total  sites  So,  So  - 
[Sk]tot, by the  bound peptide, B:  B/So  =  KF/[1  +  KF  + 
otKI] (21).  The total amount of peptide  is much smaller 
than the total concentration of skeletal binding sites, i.e., 
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4.1,  Io  -=  [4.1]tot.  Subscript  zeros  indicate  total  cellular 
concentrations  assuming  homogeneous  solutions  of  spe- 
cies inside ghosts. The quantity [3 should be small because, 
unlike, for example, band 3, most of protein 4.1 is retained 
in Triton  skeletons of membranes  (43).  If B  ~  I  and I 
~[Sk]tot ,  then  with  ct'  =  et[3 and  assuming  tx'  is  of order 
one,  the  binding  isotherm  becomes:  B/F  ~  So/[(1/K)  + 
edSo]. The binding data that define F  as the sum of exter- 
nal free and internal free (Fig. 4, B  and C), give K  =  (0.8 _+ 
0.1)  ×  106 M -1, ct',--,1.  Using just the  internal  free (Fig.  4 
A)  which  includes  resealing  with  salt  at  37°C  and  may 
therefore  give the  coarser measure,  we  get K  =  5  x  106 
M -1, ed~0.2. 
The order of magnitude of K estimated for SAB interac- 
tions with the membrane is comparable to spectrin binding 
in  solution  (11).  However,  since  actin  is  present  in  the 
membranes as well, a ternary complex with peptide should 
form in the membrane so that a more appropriate compar- 
ison  is  to  an  apparent  binary  association  constant,  Ksp 
(M-l),  for the first phase of spectrin-limited peptide bind- 
ing to actin in a  ternary-complex.  As in the ternary-com- 
plex analysis, Ksp ~  (So/2)K3; hence a  Ksp r"-'10  6 M -1 is esti- 
mated from K3 ~" 1012 M -2 and So ~  2 txM. 
The  incorporation  kinetics  data  were  fit  (Fig.  4  D)  by 
the solution of two coupled ordinary differential equations 
based on the competitive binding model (Eqs.  2a and 2b) 
and using K  =  0.9  x  106 M -1, ct~5, [3 =  0.04 to 0.2, and kf 
=  0.5  ×  10  4 M-is -1.  Thus,  endogenous  protein  4.1  has  a 
slight kinetic  advantage  (fivefold) in binding to the skele- 
ton from its vantage point on integral membrane proteins. 
Membrane Localization of Fluorescent SAB Peptide 
In Situ 
As a  means  of explicitly verifying membrane localization 
and  proper  integration  into  network  structure,  fluores- 
cently  labeled  molecules  in  resealed  ghosts  were  imaged 
after aspirating  a  ghost into  a  glass micropipette  (Fig.  5). 
The  phospholipid  analogue  FL-PE  readily  intercalates 
into  the  bilayer  and  gives a  definitive  edge-brightness  to 
the image of the sphere outside the pipette (Fig. 5 B). Flu- 
orescein-labeled antibody fragment against spectrin (Fig. 5 
C) and fluorescein  or rhodamine-phalloidin  (Fig.  5 D) la- 
bel  only the  inner  surface  of membranes.  The  phalloidin 
presumably binds to F-actin (~4  x  105 sites per cell [19]). 
Both  FITC-4.1  (Fig.  5  E)  and  IAF-GST-21.43  (Fig.  5  F) 
showed  moderate  edge  brightness  inside  4.1-deficient 
ghosts  (~2  x  105  skeletal  sites  per  cell  [19,  26])  as  ex- 
pected  from  the  radiometric  binding  analyses.  IAF-GST 
(Fig.  5  G),  albumin,  and  dextran  controls  appeared  only 
diffusely distributed in the cytoplasm at all concentrations. 
Antifluorescein  IgG bound readily to FL-PE-labeled  cells 
(Fig. 5  G). A  rhodamine-labeled  mAb fragment recogniz- 
ing GPI-anchored  CD-59 (~4  x  104 sites per cell [22]) la- 
beled membranes only dimly (12) even near saturation  in 
binding. 
Conventional  microscopy was used for most of the  im- 
aging since it provides a  sensitivity advantage, but optical 
sectioning  (Fig. 6 A, inset) was also used to clearly verify 
edge enrichment.  Quantitatively, for a sphered ghost cyto- 
plasmic  vol  of ~150  ~m  3 filled  by unbound  label  and  a 
Figure  5.  Images  of  fluores- 
cently  labeled  membrane  com- 
ponents on red cells or resealed 
ghosts in the  aspirated configu- 
ration. (A) Bright-field image of 
an  osmotically  pressurized  red 
cell  after  aspiration  into  a  mi- 
cropipette  (see  Materials  and 
Methods; 12). (B) Typical distri- 
bution of the lipid bilayer as la- 
beled  with  FL-PE.  Inset  figure 
shows  the  integrated  intensity 
profile  obtained  by  summing 
pixel intensities across the diam- 
eter of the aspirated projection. 
The pipette entrance is indicated 
with an arrow. The largest peak 
in  the  profile  arises  from  the 
portion of the sphere's image di- 
ametrically opposite the pipette 
entrance. Note the uniformity of 
response  along  the  projection. 
(C, D, and E) Typical deforma- 
tion response of the red cell skel- 
eton as revealed by spectrin-, ac- 
tin-, or 4.I-labeled red cell ghosts, 
respectively. Probes were incor- 
porated  by  reversible  hemoly- 
sis. Anti-spectrin  antibody frag- 
ments and rhodamine-phalloidin 
were used  to label spectrin  and 
F-actin,  respectively.  FITC-4.1 
was incorporated in 4.1-deficient 
red  cell  ghosts.  Inset  figures 
show  the  integrated  intensity 
profiles; the intensity at the tip is 
well above zero. Note the strong 
decrease  from  the  pipette  en- 
trance  to  the  tip  of the  projec- 
tion which contrasts with the lipid 
profile. Also note the relative uniformity of signal along the rim 
of the sphere's image. (F) A similar distribution in the projection 
of 4.1-deficient  red cells containing bacterially expressed GST- 
21.43 labeled with IAF. The dye/protein ratio was 1:1.6 and the 
IAF-labeled peptide could inhibit binding of radioactive 21.59 to 
normal membranes. (G) Incorporation of fluoresceinated  GST 
as a control for F. No membrane association and no graded re- 
sponse in the aspirated projection were observed in the range of 
1 to 15  txM. (H) Distribution  of lipid-linked  IgG. Anti-fluores- 
cein  antibodies  were  bound  to FL-PE-labeled  red  cells.  Anti- 
body fragment-labeled, GPI-anchored CD-59 gave a similar re- 
sponse of protein concentrated at the tip of the projection (12). 
range  in  skeletal  thickness  between  5  and  100  nm  (esti- 
mated from either  actin monomer dimensions  or spectrin 
dimer  contour  length;  5)  binding  sites  at  the  membrane 
would be enriched relative to the cellular concentration by 
between  200-  and  12-fold,  respectively.  For  protein  4.1, 
these numbers imply that its apparent concentration at the 
membrane  ranges  between  36  and  600  txM,  substantially 
higher  than  its mean  cellular  concentration  of 3  p,M.  As 
further evidence, edge brightness with rhodamine-phalloi- 
din was measured as a function of added phalloidin (Fig. 6 
A); a fit of the phalloidin-binding  data with a simple bimo- 
lecular model indicated  a high-affinity membrane associa- 
tion constant that was within a factor of 7 of in vitro mea- 
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normal ghost membrane. Left inset image is a rhodamine-phalloi- 
din-labeled ghost imaged with a confocal microscope; right image 
is taken with a conventional  fluorescence  microscope. The curve 
indicates  edge intensity of images using conventional microscopy 
and measured as a function of total phalloidin added. Rhodamine- 
phalloidin  was serially diluted in lysis buffer, after measuring the 
highest  concentration using  a dye/phalloidin  ratio of 1:1  and a 
peak absorptivity of 76,000 M-lcm  -1. The fitted curve used 2 × 
10  -7 M for the concentration of F-actin binding sites as calculated 
from 4 ×  105 actin molecules per membrane (19) and the volume 
of ceils lysed. The apparent association constant is 0.33 ×  10  7 M  -1 
which is slightly weaker than in vitro assays. Average +SD are 
shown for at least nine ghosts labeled at each concentration.  (B) 
Localized network stretching conformations and SAB peptide in- 
tegration. Plot of a typical network density profile,  ~, on an aspi- 
rated membrane projection along with calculated  stretch ratios: 
axial stretch, hi, and circumferential  stretch, ha (see Materials  and 
Methods).  The abscissa is in the shape of the aspirated projec- 
tion, and shows the axial distance  z scaled by the pipette radius 
Rp. To the left of the projection is illustrated  a square piece of the 
cytoskeletal meshwork before deformation. This meshwork is di- 
lated at the tip of the projection, and about halfway down the cyl- 
inder the meshwork is in a rectangular state of pure shear. The 
principal  directions  of stretch and the deformation of an initial 
square are also sketched on the projection. 
surements for phalloidin binding to F-actin. These coarse 
calculations together with the confocal image (Fig. 6 A, in- 
set) provide more explicit illustrations  of the membrane- 
concentrating  effect  and  demonstrate  that  physiological 
concentrations  can be much higher  than the  micromolar 
range. 
In Situ Integration into the Solidlike 
Cytoskeletal Network 
In cells other than erythrocytes, actin-binding proteins lo- 
calize  to  stress  fibers,  focal  contacts,  and  a  number  of 
other structures (e.g., 34). If one were to deform reversibly 
such cells and redistribute  the  structures,  one would  still 
expect to see a  colocalization of the actin and actin-bind- 
ing proteins to the same redistributed structures. In the as- 
pirated images of Fig. 5 then, specificity of localization and 
structural  connectivity are  indicated  by the  fluorescence 
patterns  obtained  after deforming the  uniformly labeled 
red cell into the micropipette (12). In short, FL-PE shows 
that  the lipid bilayer convects like a  fluid sheet  to cover 
uniformly (Fig. 5 B) a strong gradient in density of the un- 
derlying  skeleton  as  labeled  with  either  antispectrin, 
rhodamine-phalloidin,  FITC-4.1, or IAF-GST-21.43 (Fig. 
5, C, D, E, and F, respectively). Formation of this density 
gradient is much like the very tangible process of pushing 
a finger into the palm of a rubber glove: looking towards 
the extreme tip of the finger, one sees that the material be- 
comes progressively more dilated. Important in contrast, is 
the finding that lipid-linked proteins, both lipid-bound an- 
tibody (Fig. 5 H) and GPI-anchored protein CD-59 (12), 
which  presumably have no means for connection  to  the 
underlying skeleton, give a response in deformation nearly 
opposite to the network probes (12, for clarification). 
Quantitative  "fingerprints"  of these  component distri- 
butions are given by the intensity sections along the pro- 
jections shown in small insets below each cell (Fig. 5, in- 
sets). For lipid probe, the intensity is nearly uniform, but 
for spectrin,  actin, 4.1,  and  recombinant SAB peptide, a 
strong gradient in density appears. Particularly note that 
these insets show the network density is nonvanishing at 
the tip of the projection. This gradient is stable (up to 30 
min) and reversible upon release from aspiration, indicat- 
ing a solidlike skeletal network and consistent with a resil- 
ient and durable membrane. The two-dimensional nature 
of  the  network  permits  calculation  (see  Materials  and 
Methods)  of how an initially small square of cytoskeletal 
meshwork can, depending on its location, be transformed 
to various rectangular conformations down the length of 
the projection (Fig. 6 B). At the very tip or cap of the pro- 
jection, the initially square bit of meshwork is simply di- 
lated in the deformation. Toward the pipette entrance, the 
material is highly stretched in the axial direction, but com- 
pressed in the lateral direction; this conformational state is 
one of extensive shearing and is a  sustainable state for a 
solidlike but not a labile, fluidlike network. The fact that 
the  SAB  peptide  gives  the  same  apparent  density  field 
along the projection as the native skeletal components, ex- 
plicitly shows integration of the peptide into the same elas- 
tic network structure whether this structure is sheared, di- 
lated,  or  compressed reversibly. This suggests  that  both 
the  SAB peptide and protein 4.1  should have similar ef- 
fects on network integrity or strength. 
Red Cell Membrane Strength Is Determined by 
SAB Peptides' Ability to Stabilize Spectrin Cross-links 
of Actin In Situ 
Red cells deficient in protein 4.1  possess membranes that 
are more fragmentable than normal membranes (46, 51). 
However, both purified, exogenous 4.1  (47) and recombi- 
nant  GST-21.59  (11)  can,  at  approximately micromolar 
cellular  concentrations,  increase  membrane  strength  to 
normal. To test this crucial aspect of in situ cellular func- 
tion of our SAB constructs, mutant red cells with deficien- 
cies in protein 4.1 were lysed in the presence of each pep- 
tide. After resealing and suspending the ghosts in a viscous 
dextran, each sample was subjected to a  membrane-frag- 
mentation assay. 
Initially, the deformation response for all the samples is 
about  the  same value  (Fig.  7),  indicating  that  all  ghosts 
start as comparably stretched ellipsoids. After a very short 
interval of sustained  deformation, however, the 4.1-defi- 
cient membranes (~40%  deficiency) show a  transition to 
steady fragmentation as indicated by the decay in the defor- 
mation  index.  Normal membranes fragment much later. 
Addition  of the  peptide  21.20  to  the  4.1-deficient  mem- 
branes did not alter the membrane fragmentation process 
(Fig. 7 A). The 21.43,  in contrast, was able to strengthen 
the 4.1-deficient membranes to a level comparable to nor- 
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Figure  7.  Membranes  can  be  strengthened  by peptides  21.43, 
21.26, and 0.59, but not 21.20 at high concentrations. Thrombin- 
cleaved, aSS-labeled peptides were added to ghosts prepared from 
partially (~40%) 4.1-deficient  red cells. Peptide added equals the 
amount of total peptide divided by the volume after addition to 
membranes. The relative strength of the resealed membranes was 
assessed  by membrane  fragmentation under fluid shear  and is 
plotted as a time-dependent  decline in deformation index.  Re- 
sponses  of  normal  (solid  line)  and  4.1(-)  membranes  (large 
dashed line) defined the range of membrane strengthening effect 
for each construct. (A) Peptide 21.20, even at very high concen- 
trations, did not alter the fragmentation rate. (B) Peptide 21.43 
restored membrane strength at as low as 1.5 txM, consistent with 
published  results  for either  purified protein 4.1  or GST-21.59, 
while  (C) increasing the concentration of 21.26 resulted in a de- 
creased  rate  of  fragmentation,  hence  increased  membrane 
strength. (D) Entrapment of 0.59 at 37 t~M and, to a lesser extent, 
at 13 I~M showed a positive effect. 
mal (Fig. 7 B), and, as with the 21.59 (11; data not shown), 
only micromolar  (,'~1.5  ~M)  concentrations  of the  21.43 
were  necessary.  Equivalent  strengthening  with  the  pep- 
tides 21.26 and 0.59 (Fig. 7, C and D, respectively) required 
much higher peptide  concentrations  (>15  ~M).  A  mea- 
sure  of specificity for these  effects is manifest in a  21.20 
concentration of ~120 ~M having no effect on membrane 
strength  (Fig.  7  A).  GST-21.10,  GST-21.20,  and  GST  in 
membranes  with  a  full,  100%  4.1  deficiency  (data  not 
shown) also showed no effect. However, X. laevis SAB, as 
might be  expected  from the  remarkable  homology with 
human SAB, considerably  strengthened  the  4.1-deficient 
human red cells (Winardi, R., unpublished data). 
For a quantitative  approach to the incorporation chem- 
istry,  we  used  aSS-labeled,  thrombin-cleaved  peptides  in 
the fragmentation assays. Measurements of the entrapped 
peptide  concentrations  showed that  the concentration of 
the inactive peptide 21.20 inside ghosts was linear over the 
full  range  of added  peptide,  extending  to  ~50  ~M  en- 
trapped.  In contrast, the amounts of 21.43, 21.26, and 0.59 
entrapped at a given concentration of added peptide were 
consistently higher than the 21.20, and appeared as an addi- 
tional, specific membrane-binding component. The amount 
of specific binding  (Fig.  8 A) was therefore  obtained  by 
subtracting  the  baseline  amount  of 21.20  physically  en- 
trapped by resealing. In addition, for the 21.43 at two con- 
Figure 8.  Binding of active peptides to 4.1-deficient  ghost mem- 
branes and predicted extent of in situ spectrin-actin interactions. 
35S-labeled peptides were entrapped inside the ghosts and used in 
the fragmentation assays of Fig. 7 B. (A) Specific  binding of la- 
beled 21.43, and 0.59, respectively, as calculated by subtracting 
the nonspecific, physical entrapment of 21.20. For the 21.43, two 
data points indicated by +  are measured after lysis as in Fig. 4; 
one + lies on the curve at N0.4 I~M. Data points in each panel are 
solid if the  strengthening  effect was nearly full  effective;  half- 
shaded  points  correspond  to  a  partial  effect  on  membrane 
strength.  Open  points  indicate  no  clear  effect  on  membrane 
strength. Curves are calculated with the ternary complex model 
(see Results) and the parameters given in Table II. Intracellular 
concentrations are with respect to cell volume; they do not reflect 
the membrane localization effect.  (B) For each peptide, the pre- 
dicted fraction of spectrin bound to actin is illustrated against a 
background shading scheme representative of the effect on mem- 
brane strength. The curves are generated from the fits of Fig. 8 A. 
No shading indicates no effect on membrane strength. Light gray 
indicates partial effect. Darker gray indicates nearly full effect. 
centrations, the amount of membrane-bound peptide after 
a second lysis was directly measured (as per Fig. 4 A), and 
was found to coincide with the calculation based on sub- 
traction of the 21.20 baseline.  When the ternary complex 
model was fit through the membrane-binding data (Fig. 8 
A), we used a value for available spectrin (0.8 ~M  =  40% 
of 2  txM) consistent with an ~40%  (32) deficiency in en- 
dogenous protein 4.1 (normally 2 IxM). The actin available 
for binding used in fitting the results (2.4 IxM; Table II) ap- 
pears to be slightly less than an estimate  (2.9 txM) based 
on the total actin content (4.1 IxM) minus the endogenous 
4.1  (60%  of 2  ~M).  Importantly,  the  trends  in  spectrin- 
dependent  binding  constants  obtained  in  vitro  (Table  I) 
are substantially replicated in the fits of binding to mem- 
brane  structures  in situ  (Table  II). Competition with  en- 
dogenous 4.1 has been ignored in this membrane-binding 
analysis, since such competition is likely to have an effect 
only at high 21.43 concentrations after the 40% of skeletal 
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Membrane 
21.43  21.26  0.59 
Ksp  -1 ~  0.75  1.5  6.5 
rap  -1 laM  8  2.9  6.5 
n  3  3  3 
*Spo laM  0.8  0.8  0.8 
*Act  o/aM  2.4  2.4  2.4 
Model fit parameters for binding of peptides to membranes (Fig. 8 A) used in frag- 
mentation assay. 
*Within 15% of estimated concentrations. 
sites left unoccupied by 4.1  become largely filled by the 
21.43. 
Full  membrane-strengthening  effect  (Fig.  8  A,  solid 
points) by the 21.43 occurs with much lower binding to the 
membrane (>0.3 p~M) than required for the 0.59 (~2 IxM). 
The underlying mechanism that gives rise to this approxi- 
mately sevenfold difference in effectiveness is significantly 
clarified, however, by calculating for each SAB construct 
the peptide-facilitated increase in spectrin-actin associa- 
tions in the membrane. This spectrin-dependent phase of 
the binding of each peptide, the first term in Eq. 1, is plot- 
ted as  the predicted fraction of membrane spectrin that 
binds to actin. A  background shading  scheme also illus- 
trates  the  effect on  membrane  strength  (Fig.  8  B).  As 
found in vitro (Fig. 2 B), spectrin-actin stabilization is very 
closely associated with material strengthening. 
Discussion 
COOH-terminal deletion constructs and an NH2-terminal 
isoform of protein 4.1's SAB domain have been assayed 
for  their  ability  to  enter  into  ternary  associations  with 
spectrin-actin in vitro and also to specifically bind, inte- 
grate  into,  and  mechanically  strengthen  red  cell  mem- 
branes in situ. Highly efficient, membrane-strengthening 
interactions involving both spectrin and actin require both 
the NH2-terminal 21  aa,  and  also the 43 residues of the 
constitutive 59-aa domain. However, a  reduced yet ade- 
quate, membrane-strengthening activity arises from either 
the 21 aa together with the first ,'-~26 residues of the 59 aa 
or just the 59 aa alone. Combined with similar findings in 
ternary complex formation in vitro, a simplistic structural 
model  of SAB  function emerges  (Fig.  9):  two  sites  for 
spectrin  interaction flank  the  ,'~26 residue  actin-binding 
site. Exactly half of the residues of the putative actin-bind- 
ing site are charged, consistent with localization to the pro- 
tein  surface.  This  sequence  also  contains  Lys  447  which, 
through deletion of this conserved 20th of 26 residues, has 
recently been implicated in both defective red cell mem- 
branes  and  an  inability to bind spectrin-actin  (30).  The 
two putative spectrin-binding sites are largely conserved 
among  species,  consistent with  our results  for X.  laevis 
21.59 (Fig. 4 B). Structural artifacts arising from peptide 
construction could contribute to the results, but prelimi- 
nary CD spectra suggest that small if any changes in global 
peptide conformation result from our deletions in primary 
structure (Schischmanoff, P. O., unpublished data). In fur- 
ther support of two spectrin sites, a tyrosine kinase phos- 
phorylates near the middle of the 21 aa (45) while a serine 
Figure 9.  Structural model of 
the SAB domain's protein in- 
teractions.  The  middle,  un- 
shaded  domain  represents 
the  proposed  actin-binding 
site of 26 residues in the con- 
stitutively expressed  59-aa domain.  Strong spectrin  binding re- 
quires both the stippled 21-aa cassette  and the striped  COOH- 
terminus ending near residue 43 of the 59-aa domain. 
kinase phosphorylates at the 40th residue of the 59 aa (23); 
both phosphoadducts  of the  SAB  have substantially re- 
duced spectrin-actin-binding activity (28, 45). Thus, in ad- 
dition  to  the very strong  genetic modulation  of activity 
provided by splicing in or out the alternative NH2-terminal 
exon, the  split in  the spectrin-binding interaction estab- 
lishes  two physiological pathways for strong modulation 
via posttranslational modification. 
Because  the  constitutive  59-aa  domain  on  its  own  is 
found functional, albeit weakly, in both gelation and mem- 
brane-strengthening assays, expression of the alternatively 
spliced 21 aa may be interpreted as a biologically efficient 
(42), rather than physically necessary means of achieving 
the red cell membrane's required strength.  It should be 
emphasized that the mean intracellular concentration of 
0.59  sufficient for fully normal  strengthening  (,'~12  ~M, 
Fig. 8) is substantially below the minimum estimate of pro- 
tein 4.1 concentration at the membrane (>36 ~M). 
After controlled, reversible aspiration of ghosts,  spec- 
trin,  actin,  4.1,  and  the  recombinant  21.43  appeared  to 
have moved collectively as  an integrated structural unit. 
Fragmentation of 4.1-deficient red cell membranes under 
high fluid shear was subsequently shown to be modulated 
by the SAB peptides' abilities to bind spectrin-actin. The 
rapid, fluid-forced fragmentation of the red cell membrane 
seems likely to be a process of catastrophic failure at the 
weakest point in the structure. In the absence of protein 
4.1, the membrane's weak point would appear to be the 
bare spectrin-actin interaction. Addition of enough of a 
recombinant  SAB  peptide,  even an inefficient stabilizer 
like the 0.59, ultimately shifts the membrane's weak point 
to another set of strength limiting interactions. Below this 
strength limit, concomitant increases in spectrin-actin sta- 
bilization and material strength, either membrane strength 
(Fig. 8 B) or gel strength (Fig. 2 A), appear roughly pep- 
tide independent. This suggests that, for all the functional 
SAB peptides, it is primarily the stabilization of spectrin 
cross-links  of F-actin  that  solidifies and  strengthens  the 
structure. 
Like  protein  4.1,  the  spectrin-actin-stabilizing  phos- 
phoprotein adducin seems to bind F-actin cooperatively 
(35). Adducin's binary interaction with actin can coopera- 
tively drive spectrin into a spectrin-actin-adducin ternary 
complex, similar perhaps to the SAB peptides 21.26 and 
0.59, which interact with spectrin only weakly (Fig. 2 A). 
13-adducin  is  also  alternatively spliced,  and  occurs  in  a 
number of tissues  as  an isoform lacking portions  of the 
spectrin-actin binding COOH-terminus (Gilligan, D. M., 
and  V.  Bennett.  1994.  Mol.  Biol.  Cell.  5:421a;  Hughes, 
C. A., and V. Bennett. 1994. MoL Biol. Cell. 5:421a). 
The present data reinforce the finding (11) that protein 
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shear-fragmentation assay, is essentially determined by its 
SAB  interactions, independent  of further associations of 
protein 4.1  with glycophorins, p55,  band 3, or phosphati- 
dylserine. A  role for glycophorin C as a site for linking the 
bilayer and network was suggested by studies showing gly- 
cophorin C-deficient red cells are more easily fragmented 
in fluid shear than normal membranes (43). However, ad- 
ditional studies of the glycophorin C deficiency have noted 
a coexisting deficiency in protein 4.1  (1), and we have re- 
cently found that addition of either purified protein 4.1 or 
just an  SAB  peptide  to red  cells  completely deficient in 
glycophorin C  strengthened  these  membranes to normal 
(Discher, D., D. Knowles, S. McGee, M. Parra, J. Conboy, 
and N. Mohandas. 1993. Mol. Biol. Cell. 4:169a).  Interest- 
ingly, like protein 4.1, red cell adducin also seems to inter- 
act with an integral membrane protein (Sinard, J. H., G. W. 
Stewart, A. C. Argent, and J. S. Morrow. 1994. MoL BioL 
Cell, 5:421a). The present results tentatively suggest, how- 
ever, that an adducin-mediated  linkage between the net- 
work and bilayer is not critical to the membrane's resis- 
tance against fluid shear fragmentation. 
A  membrane compartmentalization role for the interac- 
tions protein 4.1 has with bilayer structures was postulated 
in our initial report of the membrane-strengthening effect 
of  the  SAB  (11).  Interactions  at  the  membrane  clearly 
have a concentrating effect (e.g., Fig. 6 A, inset).  For pro- 
tein  4.1,  peripheral  interactions  with  bilayer  structures 
would  tend  to  accelerate  its  interactions  with  network 
spectrin and actin. Quantitative evidence for this hypothe- 
sis was provided,  to a  limited  extent, by the competitive 
binding of SAB to normal membranes: multifunctional 4.1 
appears to have a  fivefold kinetic advantage in competi- 
tion for network binding. The net result of this mechanism 
for  membrane  localization may  be  an  evolved  effort  to 
economize with  a  fixed  and minimal amount of protein. 
Splicing in the 21-aa cassette has a similar effect as it tre- 
mendously increases SAB activity and thereby reduces the 
amount of free protein. Both of these mechanisms for the 
enhanced binding of 4.1 to spectrin-actin in situ thus act to 
minimize the total amount of protein needed for network 
stabilization.  The  studies  presented  here  on  the  mecha- 
nochemistry of protein 4.1's  SAB  domain therefore sup- 
port the idea that, besides the possibilities of contributing 
directly to cell mechanical properties, multiplicity in struc- 
tural protein interactions can play an important role in cell 
protein economics. 
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